These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32271517)

  • 21. A survey of the FDA's AERS database regarding muscle and tendon adverse events linked to the statin drug class.
    Hoffman KB; Kraus C; Dimbil M; Golomb BA
    PLoS One; 2012; 7(8):e42866. PubMed ID: 22936996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The long-term effect of statins on the risk of new-onset diabetes mellitus in elderly Taiwanese patients with hypertension and dyslipidaemia: a retrospective longitudinal cohort study.
    Ma T; Chang MH; Tien L; Liou YS; Jong GP
    Drugs Aging; 2012 Jan; 29(1):45-51. PubMed ID: 22191722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis of ovarian cancer in women with type 2 diabetes using metformin and other forms of antidiabetic medication or statins: a retrospective cohort study.
    Urpilainen E; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Arima R; Kangaskokko J; Puistola U; Hinkula M; Läärä E
    BMC Cancer; 2018 Jul; 18(1):767. PubMed ID: 30055585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential and Joint Effects of Metformin and Statins on Overall Survival of Elderly Patients with Pancreatic Adenocarcinoma: A Large Population-Based Study.
    E JY; Lu SE; Lin Y; Graber JM; Rotter D; Zhang L; Petersen GM; Demissie K; Lu-Yao G; Tan XL
    Cancer Epidemiol Biomarkers Prev; 2017 Aug; 26(8):1225-1232. PubMed ID: 28619830
    [No Abstract]   [Full Text] [Related]  

  • 25. Protective Effects of Different Classes, Intensity, Cumulative Dose-Dependent of Statins Against Primary Ischemic Stroke in Patients with Type 2 Diabetes Mellitus.
    Yu JM; Chen WM; Shia BC; Wu SY
    Curr Atheroscler Rep; 2023 Sep; 25(9):619-628. PubMed ID: 37515725
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin Improves Survival in Patients with Pancreatic Ductal Adenocarcinoma and Pre-Existing Diabetes: A Propensity Score Analysis.
    Amin S; Mhango G; Lin J; Aronson A; Wisnivesky J; Boffetta P; Lucas AL
    Am J Gastroenterol; 2016 Sep; 111(9):1350-7. PubMed ID: 27430290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States.
    Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE
    Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin in the prevention of hepatocellular carcinoma in diabetic patients: A systematic review.
    Cunha V; Cotrim HP; Rocha R; Carvalho K; Lins-Kusterer L
    Ann Hepatol; 2020; 19(3):232-237. PubMed ID: 31836424
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Individual and joint effects of metformin and statins on mortality among patients with high-risk prostate cancer.
    Tan XL; E JY; Lin Y; Rebbeck TR; Lu SE; Shang M; Kelly WK; D'Amico A; Stein MN; Zhang L; Jang TL; Kim IY; Demissie K; Ferrari A; Lu-Yao G
    Cancer Med; 2020 Apr; 9(7):2379-2389. PubMed ID: 32035002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature.
    Kim MH; Kim MY; Salloum S; Qian T; Wong LP; Xu M; Lee Y; Shroff SG; Sadreyev RI; Corey KE; Baumert TF; Hoshida Y; Chung RT
    Hepatol Commun; 2022 Sep; 6(9):2581-2593. PubMed ID: 35712812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Diabetes and Glucose-Lowering Therapies on Hepatocellular Carcinoma Incidence and Overall Survival.
    Hydes TJ; Cuthbertson DJ; Graef S; Berhane S; Teng M; Skowronska A; Singh P; Dhanaraj S; Tahrani A; Johnson PJ
    Clin Ther; 2022 Feb; 44(2):257-268. PubMed ID: 35078642
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative risk of lipophilic and hydrophilic statins on incident depression: A retrospective cohort study.
    Dave CV; Winterstein AG; Park H; Cook RL; Hartzema AG
    J Affect Disord; 2018 Oct; 238():542-546. PubMed ID: 29936394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins.
    Andrews TC; Ballantyne CM; Hsia JA; Kramer JH
    Am J Med; 2001 Aug; 111(3):185-91. PubMed ID: 11530028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
    Simon TG; Bonilla H; Yan P; Chung RT; Butt AA
    Hepatology; 2016 Jul; 64(1):47-57. PubMed ID: 26891205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metformin modifies disparity in hepatocellular carcinoma incidence in men with type 2 diabetes but without chronic liver diseases.
    Wang CP; Kuhn J; Shah DP; Schmidt S; Lam YF; MacCarthy D; Tenner L; Ramirez AG
    Cancer Med; 2019 Jun; 8(6):3206-3215. PubMed ID: 30993905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 2 Diabetes and Metformin Use Associate With Outcomes of Patients With Nonalcoholic Steatohepatitis-Related, Child-Pugh A Cirrhosis.
    Vilar-Gomez E; Calzadilla-Bertot L; Wong VW; Castellanos M; Aller-de la Fuente R; Eslam M; Wong GL; George J; Romero-Gomez M; Adams LA
    Clin Gastroenterol Hepatol; 2021 Jan; 19(1):136-145.e6. PubMed ID: 32389886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low-dose aspirin, statins, and metformin and survival in patients with breast cancers: a Norwegian population-based cohort study.
    Löfling LL; Støer NC; Andreassen BK; Ursin G; Botteri E
    Breast Cancer Res; 2023 Aug; 25(1):101. PubMed ID: 37649039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Association of Metformin, Other Antidiabetic Medications, and Statins With the Prognosis of Colon Cancer in Patients With Type 2 Diabetes: A Retrospective Cohort Study.
    Erkinantti S; Hautakoski A; Sund R; Arffman M; Urpilainen E; Puistola U; Jukkola A; Peeter K; Läärä E
    Cancer Control; 2022; 29():10732748221134090. PubMed ID: 36422298
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
    Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
    Kim G; Jang SY; Nam CM; Kang ES
    J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.